DJ Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ advanced 2.37% to $11.25 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.18% to 16,801.54 and Dow Jones Industrial Average falling 0.51% to 39,671.04.
The stock's rise snapped a four-day losing streak.
Inovio Pharmaceuticals Inc. closed $3.50 short of its 52-week high ($14.75), which the company achieved on April 1st.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ rose 1.49% to $153.50, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ rose 3.64% to $29.60.
Trading volume (527,004) eclipsed its 50-day average volume of 385,530.
Data source: Dow Jones Market Data, FactSet. Data compiled May 22, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 22, 2024 17:30 ET (21:30 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments